Editorial: After dopa.
D001058:Apomorphine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002628:Chemoreceptor Cells / Q000187:drug effects; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D013268:Stimulation, Chemical
D007980:Levodopa; D001058:Apomorphine